A 77 year old black patient is admitted to the hospital for a gastrointestinal bleed. He has a past medical history of CAD (MI 15 years ago), CKD (stage 4), atrial fibrillation, PUD, and hyperlipidemia for which he is taking ASA 81 mg daily, metoprolol tartrate 50 mg twice a day, atorvastatin 20 mg daily, lisinopril 20 mg daily, omeprazole 20 mg daily, and dabigatran 75 mg orally twice a day. Initial labs indicate an aPTT of 95 seconds, hemoglobin of 6.8 g/dL, and serum creatinine 2.3 mg/dL.
HughesMedicine - Pharmacotherapy Pearls from the Internal Medicine Clinical Pharmacist
Sunday, October 25, 2015
Recommended for you
-
The American Geriatrics Society recently published their Alternative Treatments to Selected Medications in reference to the most recent upd...
-
A 55 year old business executive is being discharged from the hospital after a brief admission for cellulitis. His only PMH is HTN and o...
-
Let’s start with a patient case. A patient is being treated with methylprednisolone 20 mg IV q6 hours for some inflammatory process and...
-
Ticagrelor is an antiplatelet medication that is commonly used for a number of cardiovascular conditions. Its mechanism is similar to th...
-
Midodrine is a peripherally-acting selective alpha1 receptor agonist . Let's take that sentence apart to see what we should expect ...
-
A 74 year old female patient presents to clinic describing dysuria and urinary frequency that started within the last few days. She has ...
-
Bleeding risk with anticoagulant and antiplatelet medications is something that we struggle with on a regular basis. Should we fully anti...
-
A 65 year old male is being treated for an infection on his forearm that developed purulent drainage within the last few days. He denies ...
-
Thrombocytopenia is a notable adverse effect of linezolid. Some of the evidence behind the onset, duration, and the extent of platelet de...
-
Testing urine for the presence of drugs has a variety of uses including assessing poisoning or overdose, pre-employment testing, substanc...
